logo
  

Home Depot Elects Ted Decker As Chair Of Board; Authorizes $15 Bln Share Repurchase

Home improvement retailer Home Depot Inc. (HD) said that its board has elected chief executive officer and president Edward "Ted" Decker as chair of the board, effective October 1, 2022. He will succeed Craig Menear, who will retire as chair effective September 30, 2022.

Decker, a 22-year veteran of The Home Depot, was named chief executive officer in March 2022. He was named president and chief operating officer in October 2020. Decker joined The Home Depot in 2000 as a director of business valuation and has held numerous strategic positions across the company.

In a separate press press release, Home Depot said it declared a second quarter cash dividend of $1.90 per share. The dividend is payable on September 15, 2022, to shareholders of record on the close of business on September 1, 2022.

The company's board authorized a new $15 billion share repurchase program, replacing its previous authorization.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
RELATED NEWS
Follow RTT